Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.

about

Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles

P2860

Q53718273-4BEAD37E-B2E8-4C25-A23E-B7EA086ECF71 Q58571995-62BDE573-20C3-431A-8810-5AB36BE4FE5E

P2860

Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.

Item

http://www.wikidata.org/entity/Q40058358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Production of highly stable sp ...... nas aeruginosa lung infection.

@en

type

Item

label

Production of highly stable sp ...... nas aeruginosa lung infection.

@en

prefLabel

Production of highly stable sp ...... nas aeruginosa lung infection.

@en

P1476

Production of highly stable sp ...... onas aeruginosa lung infection

@en

P2093

Ash Mathai

http://www.w3.org/2001/XMLSchema#string

Elizabeth Kutter

http://www.w3.org/2001/XMLSchema#string

Hak-Kim Chan

http://www.w3.org/2001/XMLSchema#string

Jennifer Wong

http://www.w3.org/2001/XMLSchema#string

Sandra Morales

http://www.w3.org/2001/XMLSchema#string

Warwick Britton

http://www.w3.org/2001/XMLSchema#string

P2860

Phage Therapy in Clinical Practice: Treatment of Human Infections

Bacteriophage therapy

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.

Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.

Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.

Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.

The role of vitrification in anhydrobiosis.

In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJPB.2017.09.002

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Rachel Yoon Kyung Chang

Jian Li

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28890220

http://www.w3.org/2001/XMLSchema#string

P932

5650506

http://www.w3.org/2001/XMLSchema#string

Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.

about

P2860

P2860

Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932